Shen LQ
ORCID: 0000-0002-0360-1296
· 1 paper in corpus
2002
Several drugs approved for a variety of indications have been shown to exhibit antiangiogenic effects. Our study focuses on the PPARgamma ligand rosiglitazone, a compound widely used in the treatment of type 2 diabetes. We demonstrate, for …